Have a personal or library account? Click to login
Design, synthesis and molecular docking of novel triazole derivatives as potential CoV helicase inhibitors Cover

Design, synthesis and molecular docking of novel triazole derivatives as potential CoV helicase inhibitors

Acta Pharmaceutica
Volume 70 (2020): Issue 2 (June 2020)
By: Nashwa Hafez Zaher,  Mohammed Ismail Mostafa and  Abdullah Yousef Altaher  
Open Access
|Jan 2020

Authors

Nashwa Hafez Zaher

nashwazah@hotmail.com

Radiation Drug Research Department National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Cairo, Egypt

Mohammed Ismail Mostafa

Department of Pharmacology, College of Veterinary Medicine, Cairo University, Gizah, Egypt

Abdullah Yousef Altaher

Department of Physiology, Biochemistry and Pharmacology, College of Veterinary Medicine, King Faisal University Alhasa
DOI: https://doi.org/10.2478/acph-2020-0024 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 145 - 159
Accepted on: Aug 8, 2019
|
Published on: Jan 16, 2020
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
triazole derivatives,
anti-MERS-CoV activity,
MERS-CoV helicase,
docking
Related subjects:
Pharmacy,
Pharmacy, other

© 2020 Nashwa Hafez Zaher, Mohammed Ismail Mostafa, Abdullah Yousef Altaher, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 70 (2020): Issue 2 (June 2020)Next article